Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Study unravels the unique patterns of brain shrinkage in Alzheimer's disease

The way in which brains shrink in those who develop Alzheimer's disease follows no specific or uniform pattern, finds a new study by researchers at UCL and Radboud University in the Netherlands.

4 Oct 2024

Researchers use smartphone data for early detection of Alzheimer's

Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia using mobility data, recorded during a smartphone-based wayfinding task on the university campus.

3 Oct 2024

Researchers make breakthrough in Alzheimer's disease drug development

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

3 Oct 2024

Revvity's EUROIMMUN launches solution for specific typing of Alzheimer's disease associated APOE gene

Revvity, Inc., announced today the launch of the in-vitro diagnostic EURORealTime™ APOE assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene. APOE genotyping is valuable to assess a patient’s risk for side effects prior to the start of an anti-amyloid (beta) therapy for Alzheimer’s disease.

3 Oct 2024

Dronabinol shows promise in reducing agitation in Alzheimer's patients

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

2 Oct 2024

NYU Langone secures NIH award to explore eye imaging for early detection of Alzheimer's and Parkinson's

Researchers at NYU Langone Health were awarded $1.6 million from the National Institutes of Health (NIH) to investigate changes in the eye that may indicate early signs of Alzheimer's disease and Parkinson's disease.

2 Oct 2024

Air pollution linked to brain changes in children

Outdoor air pollution from power plants, fires and cars continues to degrade human, animal and environmental health around the globe.

1 Oct 2024

Collaborative initiative seeks to uncover ways to reduce Alzheimer’s and dementia risk

The Triangulation of Innovative Methods to End Alzheimer's Disease project will use large, diverse datasets to examine whether interventions targeting alcohol use, depression, vision or hearing impairments, or social isolation can protect people from Alzheimer's disease and related dementias.

30 Sep 2024

Two genetic variants linked to Alzheimer's trigger microglial inflammation in females

Weill Cornell Medicine investigators have found that two genetic variants that confer high risk of Alzheimer's disease (AD) together trigger a harmful inflammatory response in the brain's immune cells, particularly in females, in a preclinical model.

30 Sep 2024

Falls linked to increased risk of dementia in older adults

In a retrospective study of Medicare claims data, researchers found dementia was more frequently diagnosed within one year of a fall compared to other types of injuries.

30 Sep 2024

Study explores whether certain brain proteins may play a role in Alzheimer's development

With a four-year, $3.3 million grant from the National Institutes of Health (NIH), researchers from Case Western Reserve University will study whether certain brain proteins may play a role in the development of Alzheimer's disease.

30 Sep 2024

New insights into astrocytes offer hope for Alzheimer's treatment

A research team led by Dr. Hoon Ryu from the Korea Institute of Science and Technology (KIST, President Sang-Rok Oh) Brain Disease Research Group, in collaboration with Director Justin C. Lee of the Institute for Basic Science (IBS, President Do-Young Noh) and Professor Junghee Lee from Boston University Chobanian & Avedisian School of Medicine, has uncovered a new mechanism involving astrocytes for treating Alzheimer's disease (AD) and proposed a novel therapeutic target.

30 Sep 2024

Phytoene increases lifespan, reduces oxidative stress and amyloid toxicity

Research indicates phytoene from microalgae protects against oxidative stress and beta-amyloid toxicity, suggesting its potential in promoting healthy aging.

30 Sep 2024

Carotenoid phytoene shows potential in slowing Alzheimer’s plaque formation and increasing lifespan

Researchers from the Colour and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra's group at the University of Kent (UK), have shown that the carotenoid phytoene increases the lifespan of the nematode Caenorhabditis elegans and can slow the onset of paralysis associated with the formation of amyloid plaques in a model of Alzheimer's disease.

26 Sep 2024

Alzheimer's Disease News and Research

Further Reading

Study unravels the unique patterns of brain shrinkage in Alzheimer's disease

Researchers use smartphone data for early detection of Alzheimer's

Researchers make breakthrough in Alzheimer's disease drug development

Revvity's EUROIMMUN launches solution for specific typing of Alzheimer's disease associated APOE gene

Dronabinol shows promise in reducing agitation in Alzheimer's patients

NYU Langone secures NIH award to explore eye imaging for early detection of Alzheimer's and Parkinson's

Air pollution linked to brain changes in children

Collaborative initiative seeks to uncover ways to reduce Alzheimer’s and dementia risk

Two genetic variants linked to Alzheimer's trigger microglial inflammation in females

Falls linked to increased risk of dementia in older adults

Study explores whether certain brain proteins may play a role in Alzheimer's development

New insights into astrocytes offer hope for Alzheimer's treatment

Phytoene increases lifespan, reduces oxidative stress and amyloid toxicity

Carotenoid phytoene shows potential in slowing Alzheimer’s plaque formation and increasing lifespan

Centenarians' stem cells unlock secrets to healthy aging

Concerns raised over safety and effectiveness of donanemab for Alzheimer’s treatment

Increasing daily consumption of flavonoid-rich foods may lower dementia risk

Calcium channel blockers show potential to restore cerebral blood flow in Alzheimer's disease

Blood microRNAs can predict conversion from mild cognitive impairment to dementia due to Alzheimer’s disease

Amyloid-β and tau disrupt brain activity, driving early cognitive decline in Alzheimer’s risk

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News